Kanavos Theofilos, Birbas Effrosyni, Zanos Theodoros P
Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA.
Cancers (Basel). 2024 Dec 29;17(1):69. doi: 10.3390/cancers17010069.
: Positron emission tomography (PET) is a valuable tool for the assessment of lymphoma, while artificial intelligence (AI) holds promise as a reliable resource for the analysis of medical images. In this context, we systematically reviewed the applications of deep learning (DL) for the interpretation of lymphoma PET images. : We searched PubMed until 11 September 2024 for studies developing DL models for the evaluation of PET images of patients with lymphoma. The risk of bias and applicability concerns were assessed using the prediction model risk of bias assessment tool (PROBAST). The articles included were categorized and presented based on the task performed by the proposed models. Our study was registered with the international prospective register of systematic reviews, PROSPERO, as CRD42024600026. : From 71 papers initially retrieved, 21 studies with a total of 9402 participants were ultimately included in our review. The proposed models achieved a promising performance in diverse medical tasks, namely, the detection and histological classification of lesions, the differential diagnosis of lymphoma from other conditions, the quantification of metabolic tumor volume, and the prediction of treatment response and survival with areas under the curve, F1-scores, and values of up to 0.963, 87.49%, and 0.94, respectively. : The primary limitations of several studies were the small number of participants and the absence of external validation. In conclusion, the interpretation of lymphoma PET images can reliably be aided by DL models, which are not designed to replace physicians but to assist them in managing large volumes of scans through rapid and accurate calculations, alleviate their workload, and provide them with decision support tools for precise care and improved outcomes.
正电子发射断层扫描(PET)是评估淋巴瘤的一种有价值的工具,而人工智能(AI)有望成为医学图像分析的可靠资源。在此背景下,我们系统地回顾了深度学习(DL)在淋巴瘤PET图像解读中的应用。
我们在PubMed上搜索截至2024年9月11日的研究,这些研究开发了用于评估淋巴瘤患者PET图像的DL模型。使用预测模型偏倚风险评估工具(PROBAST)评估偏倚风险和适用性问题。根据所提出模型执行的任务对纳入的文章进行分类和呈现。我们的研究已在国际前瞻性系统评价注册库PROSPERO上注册,注册号为CRD42024600026。
从最初检索到的71篇论文中,最终有21项研究、共9402名参与者被纳入我们的综述。所提出的模型在各种医学任务中取得了有前景的表现,即病变的检测和组织学分类、淋巴瘤与其他疾病的鉴别诊断、代谢肿瘤体积的量化以及治疗反应和生存的预测,曲线下面积、F1分数和 值分别高达0.963、87.49%和0.94。
几项研究的主要局限性是参与者数量少且缺乏外部验证。总之,DL模型可以可靠地辅助淋巴瘤PET图像的解读,其目的不是取代医生,而是通过快速准确的计算帮助他们处理大量扫描,减轻他们的工作量,并为他们提供精确护理和改善结果的决策支持工具。